A NOVEL DOUBLE-TRACER TECHNIQUE TO CHARACTERIZE ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION OF ORAL [14C]VORASIDENIB AND CONCOMITANT INTRAVENOUS MICRODOSE ADMINISTRATION OF [13C315N3]VORASIDENIB IN HUMANS.

Prakash, C; Yin, F; Le, K; Liu, H; Hassan, I; Lane, B; Yang, H

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021; 109 (): S33